Improved functionality and potency of next generation BinMLV viral vectors toward safer gene therapy.

Mol Ther Methods Clin Dev · 2021 · PMC8433069 · PMID 34553002

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

weakly significantp < 0.05actually significant

MABs transduced with MLV WT -EFS showed a comparable fold differentiation index compared to no vector control MABs that was only weakly significant ( Figures 7 A and 7C; Kruskall-Wallis with uncorrected Dunn’s test, ∗p < 0.05).

also in 1,387 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.